|
|
|
Volumn 3, Issue 4, 2004, Pages 460-461
|
|
Inhibition of the p53-hdm2 interaction with low molecular weight compounds.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MDM2 PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
PROTEIN MDM2;
PROTEIN P53;
ANIMAL;
APOPTOSIS;
ARTICLE;
CANCER TRANSPLANTATION;
CHEMISTRY;
CLINICAL TRIAL;
DRUG DESIGN;
HUMAN;
METABOLISM;
NEOPLASM;
PROTEIN BINDING;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL LINE, TUMOR;
CLINICAL TRIALS;
DRUG DESIGN;
HUMANS;
NEOPLASM TRANSPLANTATION;
NEOPLASMS;
NUCLEAR PROTEINS;
PROTEIN BINDING;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 3242768140
PISSN: 15384101
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
